ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Results of therapeutic phlebotomy in patients with hemochromatosis

Results of therapeutic phlebotomy in patients with hemochromatosis
Complications of iron overload Expected treatment outcome
None Prevention of complications of iron overload; normal life expectancy
Weakness, fatigue, lethargy Improvement in majority of patients
Elevated serum concentrations of hepatic enzymes Resolution or marked improvement
Hepatomegaly Resolution often occurs
Hepatic cirrhosis No change
Increased risk for primary liver cancer No change*
Right upper quadrant pain Resolution or marked improvement
Arthropathy Improvement in arthralgias sometimes occurs; change in joint deformity is rare; progression is sometimes seen
Hypogonadotrophic hypogonadism Resolution is rare
Diabetes mellitus Occasional improvement, often temporary
Hypothyroidism, hypogonadism Resolution is rare
Cardiomyopathy Resolution sometimes occurs
Hyperpigmentation Resolution usually occurs
Hyperferritinemia Resolution
Excess absorption and storage of nonferrous metalsΔ  
Infection with Vibrio vulnificus or other bacteria Little or no change
* Increased risk occurs only in persons with cirrhosis.
¶ Right upper quadrant pain in persons with hemochromatosis is often related to hepatic iron overload. In these cases, therapeutic phlebotomy usually results in marked improvement or resolution. However, right upper quadrant pain may also be caused by primary liver cancer, portal vein thrombosis, gallbladder disease, lesions in the hepatic flexure, or nephrolithiasis. Iron depletion alone will not alleviate right upper quadrant pain due to these causes.
Δ Cobalt, manganese, zinc, and lead.
Adapted from: Barton JC, McDonnell SM, Adams PC, et al. Management of hemochromatosis. Hemochromatosis Management Working Group. Ann Intern Med 1998; 129:932.
Graphic 68740 Version 8.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟